InsiderClue
← All stocks

Travere Therapeutics, Inc.

TVTX Mostly scheduled
CIK 0001438533 #1223 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$2.02M
$0.00 on a plan · $1.98M straight out of an exercise
Sold at will
$42.61K
1 of 10 sales
Net
−$2.02M
−$42.61K against sales at will

By person

16 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Meckler Jeffrey A
Director
—
$1.35M (4) scheduled
−$1.35M
91,500
0.0971%
$6.23M
+13.0%
LYONS GARY A
Director
—
$632.85K (5) scheduled
−$632.85K
61,500
0.0652%
$4.19M
+20.6%
Cline Christopher R.
CHIEF FINANCIAL OFFICER
—
$42.61K (1)
−$42.61K
118,016
0.1252%
$8.04M
+58.2%
Dube Eric M
CHIEF EXECUTIVE OFFICER
—
—
—
432,886
0.4592%
$29.47M
+19.6%
Heerma Peter
CHIEF COMMERCIAL OFFICER
—
—
—
140,684
0.1492%
$9.58M
+30.3%
ROTE WILLIAM E.
Chief Research Officer
—
—
—
115,474
0.1225%
$7.86M
+33.0%
Inrig Jula
CHIEF MEDICAL OFFICER
—
—
—
112,770
0.1196%
$7.68M
+82.0%
REED ELIZABETH E
Chief Legal Officer and GC
—
—
—
105,211
0.1116%
$7.16M
+31.3%
Coughlin Timothy
Director
—
—
—
56,250
0.0597%
$3.83M
+14.8%
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
—
—
—
42,353
0.0449%
$2.88M
−18.6%
Baynes Roy D.
Director
—
—
—
41,500
0.0440%
$2.83M
+33.9%
Squarer Ron
Director
—
—
—
39,375
0.0418%
$2.68M
+36.4%
Orwin John A
Director
—
—
—
39,375
0.0418%
$2.68M
+36.4%
Poole Sandra
Director
—
—
—
34,000
0.0361%
$2.31M
+44.7%
Bruhn Suzanne Louise
Director
—
—
—
32,750
0.0347%
$2.23M
+47.2%
Williams Brinkley Ruth
Director
—
—
—
29,750
0.0316%
$2.03M
+54.5%

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 30,000
History held since 2 Sep 2016